Separated Animal Oil Or Solidified Form Thereof Derived From Animal Flesh And Other Than From Liver Or Dairy Type Patents (Class 424/522)
-
Patent number: 7838038Abstract: A biomaterial prepared from a process comprising dehydrating the fish scales until the fish scales containing less than about 50% of water, and grinding the dehydrated fish scales into ground particles each having an average size of less than about 10,000 ?m in diameter, wherein the ground particles contain a mixture of sponge like matrix and powder is provided. The invention also provides a biomaterial prepared from fish scales by a process comprising subjecting the fish scales to a heat treatment at a temperature of less than about 200° C.Type: GrantFiled: July 31, 2007Date of Patent: November 23, 2010Inventors: Chien-Cheng Lin, Horng-Ji Lai, Shang-Ming Lin
-
Publication number: 20100130610Abstract: The invention relates to a process for the preparation of deodorized and stabilized food-grade marine oils by submitting marine oils to a counter-current steam distillation (CCSD) in a thin film column containing a structured packing and, if desired, adding antioxidant(s), to the food-grade marine oils thus obtained and to their uses in the food/feed, cosmetic and/or pharmaceutical industry.Type: ApplicationFiled: May 9, 2008Publication date: May 27, 2010Inventors: Andreas Keller, Ingo Koschinski, Albert Lustenberger, Neil Macfarlane, Thomas Meierhans
-
Publication number: 20090258080Abstract: A composition is provided comprising emu oil and processed whole fruit. The composition is in a form for either topical application to human skin or for internal ingestion.Type: ApplicationFiled: June 17, 2009Publication date: October 15, 2009Inventor: Raymond M. Pleva
-
Publication number: 20090208587Abstract: The central nervous system (CNS), i.e. the spinal cord and the brain, contains a large amount of various lipids, collectively called CNS lipids. These lipids are essential for embryonic induction but are also active in the adult body in keeping our cells in healthy normal function. By actively incorporating these normal vital CNS lipids in functional foodstuffs, it is possible to improve the immunity of a person by ingestion of such foodstuffs. The problem associated with the addition of brain substance to the diet is associated with bad taste and unpleasant attributes of the brain substance. The present invention discloses CNS lipids containing foodstuffs without the unpleasant taste and other attributes of the brain substance. The present invention relates to dairy based foodstuffs where normal fats and lipids have been replaced by CNS lipids.Type: ApplicationFiled: June 13, 2007Publication date: August 20, 2009Inventor: Thomas Tallberg
-
Patent number: 7572464Abstract: Lipids (including fatty acids) are extracted from animal solids such as powdered, freeze dried or fresh meat of green lipped mussel (Perna canaliculus) by mixing said solids with a solvent such as acetone capable of dissolving lipids therefrom to form a solvent extract, removing solvent from said extract by nanofiltration to produce a concentrated lipid extract and recovered solvent, and removing further solvent from the concentrated extract by rotary evaporation to leave extracted lipids particularly rich in eicosatetraenoic acids (ETA's).Type: GrantFiled: January 28, 2005Date of Patent: August 11, 2009Assignee: Bionovate LimitedInventors: Anthony Michael Chandler, Peter Andrew Whitton, Andre Ka-chun Lau
-
Publication number: 20090186095Abstract: The invention utilizes the transdermal properties of oil from the Australian native Emu bird (Dromais Novae-Hollandiae) to deliver the specific therapeutic grade essential oil blend of Rosemary, Thyme, Lavender and Cedarwood through the human scalp to the hair root below, thus stimulating hair growth in live hair follicles.Type: ApplicationFiled: January 17, 2008Publication date: July 23, 2009Inventor: Jennifer Lynn Bowers Bahney
-
Patent number: 7544363Abstract: The present invention discloses compositions derived from an isolated Bacillus species spores, or an extracellular product of Bacillus coagulans comprising a supernatant or filtrate of a culture of said Bacillus coagulans strain, suitable for topical application to the skin or mucosal membranes of a mammal, which are utilized to inhibit the growth of bacterium, yeast, fungi, virus, and combinations thereof. The present invention also discloses methods of treatment and therapeutic systems for inhibiting the growth of bacterium, yeast, fungi, virus, and combinations thereof, by topical application of therapeutic compositions which are comprised, in part, of isolated Bacillus species, spores, or an extracellular product of Bacillus coagulans comprising a supernatant or filtrate of a culture of said Bacillus coagulans strain.Type: GrantFiled: October 12, 2007Date of Patent: June 9, 2009Assignee: Ganeden Biotech, Inc.Inventor: Sean Farmer
-
Patent number: 7541042Abstract: The present invention discloses compositions derived from an isolated Bacillus species, spores, or an extracellular product of Bacillus coagulans comprising a supernatant or filtrate of a culture of said Bacillus coagulans strain, suitable for topical application to the skin or mucosal membranes of a mammal, which are utilized to inhibit the growth of bacterium, yeast, fungi, virus, and combinations thereof. The present invention also discloses methods of treatment and therapeutic systems for inhibiting the growth of bacterium, yeast, fungi, virus, and combinations thereof, by topical application of therapeutic compositions which are comprised, in part, of isolated Bacillus species, spores, or an extracellular product of Bacillus coagulans comprising a supernatant or filtrate of a culture of said Bacillus coagulans strain.Type: GrantFiled: June 14, 2005Date of Patent: June 2, 2009Assignee: Ganeden Biotech, Inc.Inventor: Sean Farmer
-
Publication number: 20090130218Abstract: The invention concerns a mixture of inclusion complexes comprising or consisting of (1) at least two different cyclodextrins selected among alpha-, beta- and gamma cyclodextrin and/or derivatives thereof, in particular derivatives thereof modified by primary and/or secondary hydroxyl groups, and (2) at least one oleaginous substance, in particular selected among animal, vegetable or synthetic oils. The invention also concerns a composition comprising or consisting of such a mixture, the use of such a mixture for preparing a medicine and a method for preparing such inclusion complexes.Type: ApplicationFiled: March 22, 2007Publication date: May 21, 2009Applicant: IN CYCLOInventors: Mohamed Skiba, Malika Lahiani, Frederic Bounoure, Pierre Dechelotte
-
Publication number: 20090047314Abstract: The invention relates to microencapsulation systems which are characterised in that they are developed from oily substances or sugars and in that they form an essentially organised assembly corresponding to stacks of crystalline structures. The inventive systems can be used for the microencapsulation of one or more substances which are of interest, such as therapeutically-active substances, or which can be used in cosmetics.Type: ApplicationFiled: August 21, 2008Publication date: February 19, 2009Applicants: Centre National de la Recherche Scientifique (C.N.R.S.), Universite Paris XIInventors: Amelie BOCHOT, Huguette Alphandary, Dominique Duchene, Elias Fattal
-
Emu-based formulations for the treatment of damaged skin by inhibiting microbial and fungal activity
Patent number: 7476379Abstract: A formula for use in treating skin aliments includes from about 20 to about 75 wt % emu oil; from about 0.10 to 33 wt % benzyl alcohol; from about 0.10 to about 33 wt % benzoin derivative; from about 0.2 to about 2 wt % allantoin; from about 0.25 to about 1.25 wt % methylparaben; from about 1.0 to about 13 wt % alkyl esters; and from about 0.01 to about 0.30 wt % propylparaben. The formula can be applied to skin of animals or humans with skin ailments. The formula can be applied is various manners, such as through an enhanced oil, a spray, an elastomeric device, a wipe, a lotion, an ointment, a cream, a gel or combinations thereof.Type: GrantFiled: February 13, 2006Date of Patent: January 13, 2009Assignee: Pearson Research & Development LimitedInventors: Maurine Pearson, Teresa Leigh Barr -
Publication number: 20090011042Abstract: An antimicrobial and antiviral barrier composition for topical application to the proximal anterior nares includes an antiseptic solution in combination with cocos nucifera (coconut oil) and one or more citrus oils such as, for example, citrus sinensis (orange oil). Various embodiments may also include one or more of the following additional ingredients: lauric acid; d-limonene; soy oil; emu oil; grapefruit seed extract; glycine soja; simmondsia chimensis (Jojoba); aloe vera; and a preservative, such as sodium benzoate, BHT, benzalkonium chloride, vitamin E.Type: ApplicationFiled: October 3, 2007Publication date: January 8, 2009Inventors: John A. Willimann, William Chandler
-
Patent number: 7459497Abstract: The present invention relates to a polymeric composition which has an excellent combination of properties for use in making seals and gaskets for utilization in appliances, automotive applications, and building applications, such as window glazing gaskets. These polymeric compositions offer excellent dimensional stability, low compression set, outstanding sealing characteristics, low temperature flexibility, heat resistance and ultra-violet light resistance.Type: GrantFiled: February 6, 2008Date of Patent: December 2, 2008Assignee: The Goodyear Tire & Rubber CompanyInventors: Manoj Ajbani, Christopher Kiehl, Thierry Florent Edme Materne
-
Publication number: 20080274203Abstract: This invention discloses new krill oil compositions characterized by having high amounts of phospholipids, astaxanthin esters and/or omega-3 contents. The krill oils are obtained from krill meal using supercritical fluid extraction in a two stage process. Stage 1 removes the neutral lipid by extracting with neat supercritical CO2 or CO2 plus approximately 5% of a co-solvent. Stage 2 extracts the actual krill oils by using supercritical CO2 in combination with approximately 20% ethanol. The krill oil materials obtained are compared with commercially available krill oil and found to be more bioeffective in a number of areas such as anti-inflammation, anti-oxidant effects, improving insulin resistances and improving blood lipid profile.Type: ApplicationFiled: March 28, 2008Publication date: November 6, 2008Applicant: AKER BIOMARINE ASAInventors: Inge Bruheim, Mikko Griinari, Snorre Tilseth, Sebastiano Banni, Jeffrey Stuart Cohn, Daniele Mancinelli
-
Publication number: 20080220082Abstract: The present invention relates to composition useful in growing hair. The compositions are particularly suited for re-growing hair in subjects who have experienced hair loss due to any cause. The compositions comprise essentially the lipoidic fraction of mammalian bone marrow. Methods of using the compositions and processes of preparing the lipoidic fraction for the compositions are also disclosed.Type: ApplicationFiled: March 9, 2007Publication date: September 11, 2008Inventor: Fatemeh Mirzaee
-
Publication number: 20080166418Abstract: The present disclosure provides for novel krill oil-based compositions, method of administration and method of manufacture which provide for the treatment and prevention of cardiovascular disease, including the reduction of one or more significant risk factors involved with cardiovascular disease. The active ingredients of the composition include krill oil, combined in one embodiment with niacin, and combined in an alternate embodiment, polymethoxylated flavones (PMFs).Type: ApplicationFiled: April 4, 2007Publication date: July 10, 2008Inventor: Scott F. Sones
-
Patent number: 7371407Abstract: An animal-derived lipid is disclosed that is useful as a carrying agent for anti-microbial formulations. Pharmaceutical and other preparations including Emu Oil are also described as profoundly useful components in anti-bacterial, anti-fungal, and anti-viral treatments. This lipid material is extracted from the Emu (Dromais Novae-Hollandiae), an indigenous bird of Australia and New Zealand. Therapeutic compositions comprising Emu Oil in combination with an extracellular product of Bacillus coagulans or Pseudomonas lindbergii strain, comprising a supernatant or filtrate of said culture suitable for topical application to the skin or mucosal membranes of a mammal are utilized to inhibit the growth of bacterium, yeast, fungi, virus, and combinations thereof. Additionally, the aforementioned therapeutic composition may also include an anti-microbial, anti-mycotic, and/or anti-viral agent.Type: GrantFiled: March 14, 2006Date of Patent: May 13, 2008Assignee: Ganeden Biotech, Inc.Inventor: Sean Farmer
-
Publication number: 20080107751Abstract: A wax composition comprises a wax and an antimicrobial agent in an amount effective to inhibit the growth of micro-organisms in the wax in both solid and liquid states. According to the preferred embodiment of the present invention, the wax composition comprises a wax that is solid at room temperature, an anti-microbial agent in an amount effective to inhibit the growth of micro-organisms in the wax in the liquid state, and the balance of the composition is at least one oil that is liquid at room temperature.Type: ApplicationFiled: March 10, 2005Publication date: May 8, 2008Inventors: Jeff Hudnall, Mindy Malynn Brashears
-
Patent number: 7238375Abstract: This invention relates to a composition of matter for producing hair growth and preventing hair loss in humans and the method for using said composition. The composition comprises four complexes and a carrier liquid, mixed together and added to any topical treatment or produced as an ingestible dietary supplement. Complexes 1, 2, and 3 are comprised of substances that prevent hair loss while Complex 4 promotes hair growth. Complex 1 is comprised of octyl butyrate and glutaminpeptides. Complex 2 comprises a mixture of minerals, plant extracts, vitamin B6, and linolenic acid. Complex 3 comprises a mixture of Ginkgo biloba extract, emu oil, a source of silicon, and a blend of amino acids. Complex 4 comprises a mixture of several plant extracts. The product should be used by the consumer at regular intervals, preferably 5 to 7 times per week in the form of a serum.Type: GrantFiled: December 20, 2004Date of Patent: July 3, 2007Inventor: Stephen C. Perry
-
Patent number: 7232579Abstract: A composition contains an inorganic substance obtained as a residue after incinerating skins of marine organisms, and chitin/chitosan. The composition is obtained by incinerating the skins of the marine organisms at a temperature within a range between 600° C. and 1000° C. to obtain the inorganic substance as a residue, obtaining a powdered inorganic substance from the inorganic substance, and kneading the powdered inorganic substance with chitin/chitosan powder.Type: GrantFiled: September 15, 2004Date of Patent: June 19, 2007Assignee: Matsumoto Dental UniversityInventor: Michio Ito
-
Patent number: 7189418Abstract: The present invention provides a method for extracting a lipid mixture having a high percentage of phospholipids comprising polyunsaturated fatty acids. The method comprises the steps of (a) heating the viscera of fish with hot water or steam; and (b) extracting from the heated viscera of fish, using a solvent, the lipid mixture containing phospholipids comprising polyunsaturated fatty acids. The lipid mixture obtained by the present method contains phosphatidylserine comprising docosahexaenoic acid and phosphatidylethanolamine comprising docosahexaenoic acid in high concentration.Type: GrantFiled: February 12, 2003Date of Patent: March 13, 2007Assignees: Kabushikikaisha Maruhachi Muramatsu, Shizuoka Prefectural GovernmentInventors: Seiichi Hiratsuka, Toshihiro Suzuki, Masayuki Hashidume, Youko Matsue, Tomoko Kitagawa, Masaaki Yokoyama, Masami Tamura, Tatsuya Fujii, Noriyuki Muramatsu
-
Patent number: 7179491Abstract: Triglyceride oil derived from marine sources, mammalian and fish, is treated with a silica at relatively low temperature under vacuum and is then further treated with a bleaching clay under vacuum and at higher temperature. The silica and the bleaching clay are then separated from the oil. The oil treated by this method is essentially free of proteinaceous materials, phosphatides and mucilage, pro-oxidant metals and very low in colored compounds, and is suitable for deodorizing. The deodorized oil is completely bland, unchanged in the concentration of the long-chain highly unsaturated fatty acids (EPA, DPA and DHA), very low in color, peroxides and secondary oxidation products, free of pesticides and has very good flavor stability. The method avoids the use of any chemicals, such as in the acid and base treatments required in conventional degumming and alkali refining of oils of marine origin. This avoids the formation of artifacts in the oil and trace contamination with chemicals.Type: GrantFiled: January 28, 2000Date of Patent: February 20, 2007Inventor: Ted Mag
-
Patent number: 7163702Abstract: This present invention discloses use of a chloroform/solvent mixture extraction at different solvent-to-feed ratios, followed by evaporation and extraction with ethyl acetate/water; followed by chromatography of the water phase in Teflon or other non-polar resin and Silica gel column chromatography for recovering of individual triterpene glycosides (saponins) of high purity from the freeze dried or spray dried cooking water or dried powderized tissues of the industrial processed sea cucumber Cucumaria frondosa. A resulting glycoside Frondoside A stimulates lysosomal activity of peritoneal macrophages, phagocytosis and oxidative burst in the macrophages at concentrations significantly less than for acute toxicity, hemolysis and sea urchin embryo toxicity.Type: GrantFiled: June 6, 2005Date of Patent: January 16, 2007Inventors: Sergey Anatolievuch Avilov, Vladimir Ivanovich Kalinin, Alexandra Sergeevna Silchenko, Dmitry Lvovich Aminin, Irina Grigorevna Agafonova, Valentin Aronovich Stonik, Peter D. Collin, Carl Woodward
-
Patent number: 7141252Abstract: A topical composition and method of preparation is disclosed wherein olive oil, bees wax, lemon juice and boric acid is combined to yield a cream for application to burns. The composition makes the patient more comfortable and has been shown to promote more rapid healing with less scarring than many other products.Type: GrantFiled: November 21, 2003Date of Patent: November 28, 2006Inventor: Eliana Soubhie
-
Patent number: 7132110Abstract: An osteogenic composition is prepared by a process including the steps of subjecting demineralized bone to an extraction medium to produce an insoluble extraction product and a soluble extraction product, separating the insoluble extraction product and the soluble extraction product, drying the soluble extraction product to remove all or substantially all of the moisture in the soluble extraction product, and combining the dried soluble extraction product of step c) with demineralized bone particles. Preferably, the process does not involve heating.Type: GrantFiled: July 15, 2002Date of Patent: November 7, 2006Assignee: IsoTis OrthoBiologics, Inc.Inventors: John F. Kay, Mark Borden, Richard Coulson, Edward King
-
Patent number: 7048950Abstract: An animal-derived lipid is disclosed that is useful as a carrying agent for anti-microbial formulations. Pharmaceutical and other preparations including Emu Oil are also described as profoundly useful components in anti-bacterial, anti-fungal, and anti-viral treatments. This lipid material is extracted from the Emu (Dromais Novae-Hollandiae), an indigenous bird of Australia and New Zealand. The present invention also discloses therapeutic compositions comprising Emu Oil in combination with an extracellular product of Bacillus coagulans or Pseudomonas lindbergii strain, comprising a supernatant or filtrate of said culture suitable for topical application to the skin or mucosal membranes of a mammal, which are utilized to inhibit the growth of bacterium, yeast, fungi, virus, and combinations thereof. Additionally, the aforementioned therapeutic composition may also include an anti-microbial, anti-mycotic, and/or anti-viral agent.Type: GrantFiled: May 11, 2004Date of Patent: May 23, 2006Assignee: Ganeden Biotech, Inc.Inventor: Sean Farmer
-
Patent number: 7029711Abstract: A transcutaneous pain relief composition for applying to the skin, comprising a mixture of dimethyl sulfoxide, stearic acid, emulsifying wax, glycerine, emu oil, sal butter, glucosamine, coconut oil, white beeswax, active calendula oil, slippery elm oil, Chamomile oil, arnica Oil, valenrian oil, peppermint oil, grapefruit seed extract, lavender oil and distilled water is disclosed.Type: GrantFiled: December 9, 2003Date of Patent: April 18, 2006Inventor: Shannon Lynn Farrell
-
Patent number: 6998109Abstract: The present formulation is an analgesic, anesthetic and anti-pruritic formulation with from about 10.0 wt % to about 75.0 wt % Emu oil; from about 10.0 wt % to about 33.0 wt % benzyl alcohol; from about 0.25 wt % to about 5.0 wt % allantoin; from about 0.1 wt % to about 5.0 wt % methylparaben; from about 0.1 wt % to about 2.0 wt % propylparaben; and from about 0.5 wt % to about 4.0 wt % of lidocaine, wherein the formulation is adapted to inhibit microbial activity from Escherichia coli, Salmonella typhimurium, Pseudomonas aeruginosa, Staphylococcus aureus, Enterococcus faecalis, Bacillus cereus, Candida albicans, Streptococcus agalactiae or combinations thereof, and wherein the lidocaine relieves pain on the epidermis of humans and animals of skin irritations, wounds, or burns.Type: GrantFiled: January 7, 2004Date of Patent: February 14, 2006Assignee: Pearson Research & Development LimitedInventors: Maurine Pearson, Teresa Leigh Barr
-
Patent number: 6921543Abstract: A method for modulating the immune response to an immunogen in a human or animal patient comprises administration to the patient of an immunogenically effective amount of the immunogen and an immunomodulatory effective amount of a lipid extract of Perna canaliculus or Mytilus edulis.Type: GrantFiled: September 21, 2001Date of Patent: July 26, 2005Assignee: Pharmalink International LimitedInventors: Larisa G Rudenko, Robert Borland, Anatoly Naychin
-
Patent number: 6905692Abstract: The present invention discloses compositions derived from an isolated Bacillus species, spores, or an extracellular product of Bacillus coagulans comprising a supernatant or filtrate of a culture of said Bacillus coagulans strain, suitable for topical application to the skin or mucosal membranes of a mammal, which are utilized to inhibit the growth of bacterium, yeast, fungi, virus, and combinations thereof. The present invention also discloses methods of treatment and therapeutic systems for inhibiting the growth of bacterium, yeast, fungi, virus, and combinations thereof, by topical application of therapeutic compositions which are comprised, in part, of isolated Bacillus species, spores, or an extracellular product of Bacillus coagulans comprising a supernatant or filtrate of a culture of said Bacillus coagulans strain.Type: GrantFiled: June 28, 2002Date of Patent: June 14, 2005Assignee: Ganeden Biotech, Inc.Inventor: Sean Farmer
-
Patent number: 6869603Abstract: The present invention is directed to compositions which include the enzyme lipoprotein lipase. These compositions may be applied topically to the skin of a person to prevent dryness or treat inflammation. In addition, the invention is directed to the use of fibrates to enhance the activity of lipoprotein lipase. The fibrates may be used orally to treat inflammation or enhance metabolic energy production.Type: GrantFiled: November 7, 2002Date of Patent: March 22, 2005Assignee: The Brigham and Women's Hospital, Inc.Inventors: Jorge Plutzky, Ouliana Ziouzenkova
-
Patent number: 6827930Abstract: A sport fishing system having: a rod and reel, including fishing line; at least one fishing lure or natural bait; and a controlled released fish attractant for applying to the fishing lure or natural bait. The system may further include an applicator for applying the controlled released fish attractant to the fishing lure or natural bait. In the preferred embodiment, the controlled release fish attractant includes: an attractant and a substantially hydrophobic, film forming release agent.Type: GrantFiled: September 6, 2002Date of Patent: December 7, 2004Assignee: Carolina Lunker Sauce, L.L.C.Inventors: Stephen Russell Cobb, Michael D. Jacobson, Joseph A. Lupia
-
Publication number: 20040208860Abstract: An animal-derived lipid is disclosed that is useful as a carrying agent for anti-microbial formulations. Pharmaceutical and other preparations including Emu Oil are also described as profoundly useful components in anti-bacterial, anti-fungal, and anti-viral treatments. This lipid material is extracted from the Emu (Dromais Novae-Hollandiae), an indigenous bird of Australia and New Zealand. The present invention also discloses therapeutic compositions comprising Emu Oil in combination with an extracellular product of Bacillus coagulans or Pseudomonas lindbergii strain, comprising a supernatant or filtrate of said culture suitable for topical application to the skin or mucosal membranes of a mammal, which are utilized to inhibit the growth of bacterium, yeast, fungi, virus, and combinations thereof. Additionally, the aforementioned therapeutic composition may also include an anti-microbial, anti-mycotic, and/or anti-viral agent.Type: ApplicationFiled: May 11, 2004Publication date: October 21, 2004Inventor: Sean Farmer
-
Publication number: 20040202722Abstract: The instant invention is directed toward a dermal delivery system composition comprising an aqueous base vehicle including American Emu oil, Isopropyl Palmitate (PROTACHEM IPP), PEG-8 (a polyethylene glycol available under the tradename PROTACHEM 400), methylsulfonylmethane (MSM) and SEPIGEL 305 (a combination including polyacrylamide/C13-C14 Iso-paraffin and LAURETH 7, in combination with an analgesic composition, such as ibuprofen, and to processes for the manufacture and use thereof.Type: ApplicationFiled: April 11, 2003Publication date: October 14, 2004Inventor: Robert Fishman
-
Patent number: 6800299Abstract: Provided herein is a method for extracting lipid fractions from marine and aquatic animal material by acetone extraction. The resulting non-soluble and particulate fraction is preferably subjected to an additional solvent extraction with an alcohol, preferably ethanol, isopropanol or t-butanol or an ester of acetic acid, preferably ethyl acetate to achieve extraction of the remaining soluble lipid fraction from the marine and aquatic animal material. The remaining non-soluble particulate contents is also recovered since it is enriched in proteins and contains a useful amount of active enzymes. Also provided herein is a krill extract.Type: GrantFiled: July 25, 2001Date of Patent: October 5, 2004Assignee: Universite de SherbrookeInventors: Adrien Beaudoin, Geneviéve Martin
-
Patent number: 6800294Abstract: There is disclosed an antiparasitic formulation comprising Eucalyptus oil, Cajeput oil, Lemongrass oil, Clove bud oil, Peppermint oil, Piperonyl and Piperonyl Butoxide. The formulation can be used for treating an animal body or in the manufacture of a medicament for treating ectoparasitic infestation of an animal or for repelling parasites.Type: GrantFiled: March 19, 2002Date of Patent: October 5, 2004Assignee: Barrier Biotech LimitedInventors: Robert Eugene Ryan, Sandra Morris
-
Publication number: 20040191327Abstract: The present invention relates to a method of preventing and/or treating asthma in animals including humans using natural compound Luteolin, said method comprising administering therapeutically effective dose of the Luteolin and leading to level of IFN-gamma increasing to normal level, levels of IL-5, IL-4, and IgE decreasing to normal level, and further, said method inhibits airway constriction, and airway hyperreactivity.Type: ApplicationFiled: November 3, 2003Publication date: September 30, 2004Applicant: Council of Scientific and Industrial ResearchInventors: Balaram Ghosh, Moumita Das, Arjun Ram
-
Publication number: 20040185088Abstract: An elastomeric article is described herein. The elastomeric article generally includes an elastomeric substrate, the elastomeric substrate including a first side and a second side, wherein the second side is opposite the first side. The elastomeric substrate further includes an absorbent layer flexibly bonded to at least a first portion of the first side. The absorbent layer includes an emu oil based composition. The elastomeric article further includes an adhesive composition applied to at least a second portion of the first side, the second portion occupying a different area of the elastomeric substruate than the first portion. The emu oil based composition includes from about 20 wt. % to about 75 wt. % of refined sterilized emu oil, from about 10 wt. % to about 33 wt. % of one or more aromatic alcohols, from about 10 wt. % to about 25 wt. % of one or more benzoic acids, from about 0.2 wt. % to about 2.0 wt. % of allantoin, from about 0.025 wt. % to about 1.25 wt. % of methylparaben, from about 1.0 wt.Type: ApplicationFiled: May 16, 2003Publication date: September 23, 2004Inventors: Maurine Pearson, Teresa Leigh Barr
-
Publication number: 20040185115Abstract: Methods and compositions for treating skin ailments are described herein. Embodiments of the invention include a therapeutic composition. The thereapeutic composition is adapted for cleansing and treating skin and further includes an emu oil based composition. The emu oil based composition includes from about 20 wt. % to about 75 wt. % of refined sterilized emu oil, from about 0.01 wt. % to about 33 wt. % of one or more aromatic alcohols, from about 10 wt. % to about 25 wt. % of one or more benzoic acids, from about 0.2 wt. % to about 2.0 wt. % of allantoin, from about 0.025 wt. % to about 1.25 wt. % of methylparaben, from about 1.0 wt. % to about 13.0 wt. % of one or more alkyl esters and from about 0.01 wt. % to about 0.30 wt. % of propylparaben. Embodiments of the invention further include a composition including an aqeous emu oil based composition, wherein the aqueous emu oil based composition is adapted for cleansing and treating skin. Embodiments of the invention further include an absorbent article.Type: ApplicationFiled: May 16, 2003Publication date: September 23, 2004Inventors: Maurine Pearson, Teresa Leigh Barr
-
Patent number: 6733751Abstract: An animal-derived lipid is disclosed that is useful as a carrying agent for anti-microbial formulations. Pharmaceutical and other preparations including Emu Oil are also described as profoundly useful components in anti-bacterial, anti-fungal, and anti-viral treatments. This lipid material is extracted from the Emu (Dromais Novae-Hollandiae), an indigenous bird of Australia and New Zealand. The present invention also discloses therapeutic compositions comprising Emu Oil in combination with an extracellular product of Bacillus coagulans or Pseudomonas lindbergii strain, comprising a supernatant or filtrate of said culture suitable for topical application to the skin or mucosal membranes of a mammal, which are utilized to inhibit the growth of bacterium, yeast, fungi, virus, and combinations thereof. Additionally, the aforementioned therapeutic composition may also include an anti-microbial, anti-mycotic, and/or anti-viral agent.Type: GrantFiled: March 10, 2003Date of Patent: May 11, 2004Assignee: Ganeden Biotech, Inc.Inventor: Sean Farmer
-
Patent number: 6726935Abstract: A pharmaceutical composition for prevention or treatment of premature ejaculation and/or hypersensitivity of sexual stimulation is provided, which contains a therapeutically effective amount of a purified essence of Bufonis venenum for prevention or treatment of dysspermia or the symptom of non-controlled ejaculation in male, due to premature ejaculation and/or hypersensitivity of sexual stimulation. The Bufonis venenum may be a purified essence of Bufonis venenum extracted by use of one or more organic solvent selected from a group consisting of ethyl acetate, dichloromethane or chloroform, and concentrated, and is purified and fractionated by use of silica gel column. The composition may be formulated in a pharmaccutically acceptable formulation of ointment, suspension, gel, spray, patch or solution.Type: GrantFiled: June 24, 2002Date of Patent: April 27, 2004Assignee: Cheil Jedang CorporationInventors: Joon Whan Ji, Jae Ku Kang, Young Hoon Kim, Sung Hak Jung, Hee Jae Cho, Kwang Hyuk Lee
-
Patent number: 6723326Abstract: The present invention discloses compositions derived from an isolated Bacillus species, spores, or an extracellular product of Bacillus coagulans comprising a supernatant or filtrate of a culture of said Bacillus coagulans strain, suitable for topical application to the skin or mucosal membranes of a mammal, which are utilized to inhibit the growth of bacterium, yeast, fungi, virus, and combinations thereof. The present invention also discloses methods of treatment and therapeutic systems for inhibiting the growth of bacterium, yeast, fungi, virus, and combinations thereof, by topical application of therapeutic compositions which are comprised, in part, of isolated Bacillus species, spores, or an extracellular product of Bacillus coagulans comprising a supernatant or filtrate of a culture of said Bacillus coagulans strain.Type: GrantFiled: July 20, 2000Date of Patent: April 20, 2004Assignee: Ganeden Biotech, Inc.Inventor: Sean Farmer
-
Patent number: 6683066Abstract: After interruption of blood supply to central nervous system tissue, cerebral edema sets in. It has been shown that restoring blood flow to injured areas of the central nervous system after the onset of edema does not result in blood reperfusing the tissue. A composition and method for treating injured central nervous tissue, or preventing injury to central nervous system tissue is provided. The composition is generally an amphipathic lipid in an oil solution. The method provides for withdrawing cerebrospinal fluid from the subarachnoid spaces around the tissue to be treated or protected, and replacing that fluid with an approximately equivalent volume of the amphipathic lipid in oil composition. The treatment can be augmented with agents that suppress production of cerebrospinal fluid, or with other known agents.Type: GrantFiled: September 24, 2001Date of Patent: January 27, 2004Inventor: Yanming Wang
-
Patent number: 6645506Abstract: The present invention discloses compositions derived from an isolated Bacillus species, spores, or an extracellular product of Bacillus coagulans comprising a supernatant or filtrate of a culture of said Bacillus coagulans strain, suitable for topical application to the skin or mucosal membranes of a mammal, which are utilized to inhibit the growth of bacterium, yeast, fungi, virus, and combinations thereof. The present invention also discloses methods of treatment and therapeutic systems for inhibiting the growth of bacterium, yeast, fungi, virus, and combinations thereof, by topical application of therapeutic compositions which are comprised, in part, of isolated Bacillus species, spores, or an extracellular product of Bacillus coagulans comprising a supernatant or filtrate of a culture of said Bacillus coagulans strain.Type: GrantFiled: August 26, 1999Date of Patent: November 11, 2003Assignee: Ganeden Biotech, Inc.Inventor: Sean Farmer
-
Publication number: 20030091650Abstract: My invention is the use of ratite oil as a topical adjuvant and as a transdermal delivery vehicle to carry agents, especially medicines, into the bodies of mammals, including humans. This patent application specifically excludes progesterone as one of the claimed agents (U.S. Pat. No. 6,303,132), and the topical use of plain emu oil (patent application 20010033838).Type: ApplicationFiled: November 13, 2001Publication date: May 15, 2003Inventor: Linda Wells
-
Patent number: 6562377Abstract: A composition to stop hair-loss and a method of making said composition with a base of paraffin oil, pure alcohol and fur of otters or minks. This composition is oily and is applied on the part of the head which suffers from hair falling. The remaining on the head is 2-3 days without hair washing with shampoos but only with tap water. The hair washing should be done every 7-14 days. The minimum duration of therapy is 2 months.Type: GrantFiled: January 16, 2001Date of Patent: May 13, 2003Inventor: George Mexis
-
Patent number: 6541519Abstract: Methods and compositions are disclosed for prevention and/or treatment of diseases in which 5- and 12-lipoxygenase activity contributes to the pathological condition, by administration of 12-methyletradecanoic acids alone and in conjunction with other therapeutic compounds. Methods to inhibit lipoxygenase-mediated inflammations are disclosed.Type: GrantFiled: April 6, 2001Date of Patent: April 1, 2003Assignee: Coastside Bio ResourcesInventors: Peter D. Collin, Peiying Yang, Robert Newman
-
Patent number: 6538027Abstract: This invention provides compositions for repelling insects, particularly biting insects, such as mosquitoes, ticks, and biting flies comprising ratite oil, active fractions of ratite oil obtained by flash chromatography or compositions comprising mixtures of fatty acids found in ratite oil. Also provided are compositions for repelling insects comprising ratite oil, active fractions of ratite oil or compositions comprising mixtures of fatty acids found in ratite oil further comprising at least one additional insect repellent. Methods of repelling insects, particularly biting insects, are provided comprising topically applying ratite oil, active fractions of ratite oil, or compositions comprising mixtures of fatty acids found in ratite oil; or ratite oil, active fractions thereof, or compositions comprising fatty acids found in ratite oil and further comprising at least one additional insect repellent.Type: GrantFiled: February 15, 2001Date of Patent: March 25, 2003Assignee: AgraQuest, Inc.Inventors: Denise C. Manker, Pamela Gail Marrone, Stephen Judd
-
Patent number: 6531126Abstract: An animal-derived lipid is disclosed that is useful as a carrying agent for anti-microbial formulations. Pharmaceutical and other preparations including Emu Oil are also described as profoundly useful components in anti-bacterial, anti-fungal, and anti-viral treatments. This lipid material is extracted from the Emu (Dromais Novae-Hollandiae), an indigenous bird of Australia and New Zealand. The present invention also discloses therapeutic compositions comprising Emu Oil in combination with an extracellular product of Bacillus coagulans or Pseudomonas lindbergii strain, comprising a supernatant or filtrate of said culture suitable for topical application to the skin or mucosal membranes of a mammal, which are utilized to inhibit the growth of bacterium, yeast, fungi, virus, and combinations thereof. Additionally, the aforementioned therapeutic composition may also include an anti-microbial, anti-mycotic, and/or anti-viral agent.Type: GrantFiled: May 7, 2001Date of Patent: March 11, 2003Assignee: Ganeden Biotech, Inc.Inventor: Sean Farmer
-
Patent number: 6528040Abstract: An analgesic, anesthetic and antipruritic formulation is provided containing 0.01 to 13 wt % alkyl esters; and 20 to 70 wt % Emu oil; 10 to 33 wt % benzyl alcohol; 10 to 33 wt % benzoin; 0.2 to 2 wt % allantoin; 0.25 to 1.25 wt % methylparaben and 0.01 to 0.30 wt % propylparaben. The formulation may be formulated as a spray or transdermal formula. The formulation may be used for treatment of chronic cutaneous ulcers and burn wounds.Type: GrantFiled: August 24, 2001Date of Patent: March 4, 2003Inventors: Maurine Pearson, Teresa L. Barr